PMID- 38435634 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240305 IS - 1178-7007 (Print) IS - 1178-7007 (Electronic) IS - 1178-7007 (Linking) VI - 17 DP - 2024 TI - Gender Differences in the Incidence of Nephropathy and Changes in Renal Function in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study. PG - 943-957 LID - 10.2147/DMSO.S451628 [doi] AB - PURPOSE: This research aims to examine and scrutinize gender variations in the incidence of diabetic nephropathy (DN) and the trajectory of renal function in type 2 diabetes mellitus (T2DM) patients. PATIENTS AND METHODS: We conducted a retrospective cohort study that enrolled 1549 patients diagnosed with T2DM from May 2015 to July 2023. We separately compared the clinical characteristics of male and female participants with and without DN. We utilized the Kaplan-Meier method to examine the cumulative incidence of DN among T2DM patients of varying genders. Hazard ratios (HR) and 95% confidence intervals (CI) were calculated using univariable and multivariable Cox proportional hazards regression analysis to evaluate the correlation between various factors and the risk of DN incidence. Multiple linear regression was utilized to investigate the relationship between DeltaeGFR% and each factor. Logistic regression with cubic spline function and smooth curve fitting was employed to analyze the nonlinear link between DeltaeGFR% and the risk of DN among participants of different genders. RESULTS: The prevalence of DN was higher in female participants (17.31%) than in male participants (12.62%), with a significant cumulative risk ratio (1.33 [1.02-1.73], P = 0.034). Multiple linear regression analysis revealed that creatinine, female gender, blood urea nitrogen, alkaline phosphatase, and total cholesterol had a significant impact on DeltaeGFR% in T2DM patients, with standardized beta coefficients of -0.325, -0.219, -0.164, -0.084, and 0.071, respectively. The restricted cubic spline analysis demonstrated a strong negative association between DeltaeGFR% and the risk of developing DN (P < 0.001). CONCLUSION: Both male and female patients with T2DM had a higher prevalence of DN over the 5-year follow-up period. However, women had a greater risk of developing DN and a faster decline in renal function compared to men. CI - (c) 2024 Zhang et al. FAU - Zhang, Fan AU - Zhang F AUID- ORCID: 0000-0001-9028-6185 AD - Department of Endocrinology, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, People's Republic of China. AD - Department of Clinical Nutrition, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, People's Republic of China. FAU - Han, Yan AU - Han Y AD - Department of Endocrinology, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, People's Republic of China. AD - Department of Clinical Nutrition, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, People's Republic of China. FAU - Zheng, Guojun AU - Zheng G AD - Clinical Laboratory, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, People's Republic of China. FAU - Li, Wenjian AU - Li W AUID- ORCID: 0000-0002-7650-8842 AD - Department of Urology, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, People's Republic of China. LA - eng PT - Journal Article DEP - 20240226 PL - New Zealand TA - Diabetes Metab Syndr Obes JT - Diabetes, metabolic syndrome and obesity : targets and therapy JID - 101515585 PMC - PMC10906732 OTO - NOTNLM OT - gender differences OT - glomerular filtration rate estimates OT - nephropathy OT - renal function OT - type 2 diabetes mellitus COIS- The authors declare no conflicts of interest in this study. EDAT- 2024/03/04 06:48 MHDA- 2024/03/04 06:49 PMCR- 2024/02/26 CRDT- 2024/03/04 05:03 PHST- 2023/12/05 00:00 [received] PHST- 2024/02/19 00:00 [accepted] PHST- 2024/03/04 06:49 [medline] PHST- 2024/03/04 06:48 [pubmed] PHST- 2024/03/04 05:03 [entrez] PHST- 2024/02/26 00:00 [pmc-release] AID - 451628 [pii] AID - 10.2147/DMSO.S451628 [doi] PST - epublish SO - Diabetes Metab Syndr Obes. 2024 Feb 26;17:943-957. doi: 10.2147/DMSO.S451628. eCollection 2024.